A “LIFE-changing” drug for breast cancer patients has been given the final go-ahead for routine NHS use in England. The National Institute for Health and Care Excellence issued its final decision recommending Perjeta, also known as pertuzumab, for some women with breast cancer.
from Daily Express :: Health Feed http://bit.ly/2FxlFJ8
via Buy Breast Actives
from Tumblr http://bit.ly/2E1v26B
No comments:
Post a Comment